Sharda Cropchem Ltd

Latent View Analytics Ltd, Aarti Pharmalabs Ltd, KNR Constructions Ltd and Mangalore Refinery And Petrochemicals Ltd are among the other gainers in the BSE's 'A' group today, 02 February 2026.Sharda Cropchem Ltd soared 7.80% to Rs 1067.15 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 56700 shares were traded on the counter so far as against the average daily volumes of 50896 shares in the past one month. Latent View Analytics Ltd spiked 5.80% to Rs 442.4. The stock was the second biggest gainer in 'A' group. On the BSE, 5.09 lakh shares were traded on the counter so far as against the average daily volumes of 15621 shares in the past one month. Aarti Pharmalabs Ltd surged 5.30% to Rs 771.05. The stock was the third biggest gainer in 'A' group. On the BSE, 9944 shares were traded on the counter so far as against the average daily volumes of 15370 shares in the past one month. KNR Constructions Ltd spurt 5.05% to Rs 148.7. The stock was the fourth biggest gainer in 'A' group. On the BSE, 2.32 lakh shares were traded on the counter so far as against the average daily volumes of 64052 shares in the past one month. Mangalore Refinery And Petrochemicals Ltd rose 4.26% to Rs 170.25. The stock was the fifth biggest gainer in 'A' group. On the BSE, 8.27 lakh shares were traded on the counter so far as against the average daily volumes of 10.69 lakh shares in the past one month. Powered by Capital Market - Live

Sharda Cropchem announced that the Board of Directors of the Company at its meeting held on 29 January 2026, inter alia, have recommended the interim dividend of Rs 6 per equity Share (i.e. 60%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Sharda Cropchem rose 365.87% to Rs 145.12 crore in the quarter ended December 2025 as against Rs 31.15 crore during the previous quarter ended December 2024. Sales rose 38.68% to Rs 1288.76 crore in the quarter ended December 2025 as against Rs 929.33 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1288.76929.33 39 OPM %18.7012.34 - PBDT261.86114.82 128 PBT178.5645.93 289 NP145.1231.15 366 Powered by Capital Market - Live

Sharda Cropchem will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live

Net profit of Sharda Cropchem rose 75.22% to Rs 74.31 crore in the quarter ended September 2025 as against Rs 42.41 crore during the previous quarter ended September 2024. Sales rose 19.59% to Rs 929.11 crore in the quarter ended September 2025 as against Rs 776.89 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales929.11776.89 20 OPM %14.3011.54 - PBDT161.90114.62 41 PBT85.7245.52 88 NP74.3142.41 75 Powered by Capital Market - Live

Consolidated revenue jumped 20% year-on-year to Rs 929.1 crore in Q2 FY26 from Rs 776.9 crore in Q2 FY25, led by higher contribution from the agrochemical segment. Net profit (PAT) jumped 75% to Rs 74.4 crore compared with Rs 42.4 crore a year ago. Gross profit rose sharply by 49% to Rs 320.7 crore from Rs 214.7 crore a year earlier, with gross profit margin expanding by 690 basis points to 34.5%. EBITDA surged 71% YoY to Rs 138.9 crore from Rs 81.3 crore, while the EBITDA margin expanded by 450 basis points to 15% from 10.5% in Q2 FY25. Segment wise, the agrochemical segment remained the company's growth engine, with revenue rising 27% YoY to Rs 803 crore, while the non-agro segment contributed Rs 126 crore, down 11% YoY. Product-wise, herbicides led the charge with 20% growth to Rs 433 crore, followed by insecticides, which surged 65% to Rs 219 crore. Fungicides posted a moderate 7% increase to Rs 150 crore. Regionally, the European market remained the top contributor, growing 15% YoY to Rs 463 crore, followed by NAFTA (North American region), which posted 69% growth to Rs 214 crore. LATAM and RoW regions also recorded double-digit growth of 21% each, with revenues of Rs 71 crore and Rs 55 crore, respectively. Ramprakash Bubna, chairman and MD, said, In Q2 FY26, we delivered robust revenue growth of 20% YoY to Rs. 929 crore, mainly driven by volumes. NAFTA and Europe remains a key contributors in both volume and value terms. With input costs stabilizing and improving price dynamics, Gross Margins has expanded by 690 basis points to 34.5% and we expect GP Margins to remain in a similar range going ahead. We expect prices to go up going forward. EBITDA has grown by 71% to Rs. ~139 crore with EBITDA Margins at 15.0% (improved by 450 bps on Y-o-Y basis). For FY26, we are on track to maintain healthy EBITDA margins in the range of 15-18%. We remain committed to accelerating product registrations in FY26, supported by a planned capital expenditure of Rs. 450-500 crore. Our strong registration pipeline of 1,068 underscores our resilience and sustained growth focus, positioning us well for the long term. Sharda Cropchem is engaged in the marketing and distribution of agrochemical formulations and generic active ingredients in fungicide, herbicide and insecticide segments globally. The stock slumped 7.53% to Rs 881.85 as investors booked profits after the stock's sharp uptrend over the past week. The counter had surged 18.74% in the last seven sessions, outpacing broader market gains. Powered by Capital Market - Live

The counter had surged 18.74% in the last seven sessions, outpacing broader market gains. The correction comes ahead of the company's board meeting scheduled today (30 October 2025) to consider and approve its financial results for the quarter ended September 2025 (Q2 FY26). Sharda Cropchem is engaged in the marketing and distribution of agrochemical formulations and generic active ingredients in fungicide, herbicide and insecticide segments globally. On a consolidated basis, net profit of Sharda Cropchem surged 423.96% to Rs 142.78 crore while net sales rose 25.44% to Rs 984.81 crore in Q1 June 2025 over Q1 June 2024. Powered by Capital Market - Live

Sharda Cropchem will hold a meeting of the Board of Directors of the Company on 30 October 2025.Powered by Capital Market - Live

Net profit of Sharda Cropchem rose 423.96% to Rs 142.78 crore in the quarter ended June 2025 as against Rs 27.25 crore during the previous quarter ended June 2024. Sales rose 25.44% to Rs 984.81 crore in the quarter ended June 2025 as against Rs 785.11 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales984.81785.11 25 OPM %21.869.81 - PBDT247.2295.57 159 PBT169.1430.79 449 NP142.7827.25 424 Powered by Capital Market - Live

Sharda Cropchem will hold a meeting of the Board of Directors of the Company on 25 July 2025.Powered by Capital Market - Live